Tony J. Ciampitti Sells 9,534 Shares of AMETEK, Inc. (NYSE:AME) Stock

Share on StockTwits

AMETEK, Inc. (NYSE:AME) insider Tony J. Ciampitti sold 9,534 shares of AMETEK stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $97.14, for a total transaction of $926,132.76. Following the transaction, the insider now owns 42,979 shares in the company, valued at approximately $4,174,980.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

AME opened at $96.54 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.48 and a current ratio of 2.05. AMETEK, Inc. has a fifty-two week low of $63.14 and a fifty-two week high of $97.30. The firm’s fifty day moving average is $90.22 and its 200 day moving average is $87.83. The stock has a market cap of $22.00 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 2.13 and a beta of 1.20.

AMETEK (NYSE:AME) last announced its quarterly earnings results on Thursday, October 31st. The technology company reported $1.06 EPS for the quarter, topping the consensus estimate of $1.01 by $0.05. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.28 billion. AMETEK had a net margin of 16.63% and a return on equity of 20.04%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 EPS. On average, equities research analysts predict that AMETEK, Inc. will post 4.14 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.58%. AMETEK’s payout ratio is currently 17.02%.

AME has been the topic of a number of analyst reports. Oppenheimer lifted their target price on shares of AMETEK from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Rosenblatt Securities initiated coverage on shares of AMETEK in a research note on Thursday. They set a “buy” rating and a $115.00 target price on the stock. KeyCorp lifted their target price on shares of AMETEK from $94.00 to $100.00 in a research note on Wednesday, July 31st. Morgan Stanley set a $102.00 target price on shares of AMETEK and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Royal Bank of Canada set a $95.00 target price on shares of AMETEK and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $97.62.

Hedge funds have recently made changes to their positions in the business. NumerixS Investment Technologies Inc purchased a new stake in AMETEK in the 2nd quarter worth $27,000. Shine Investment Advisory Services Inc. lifted its stake in AMETEK by 67.8% in the 3rd quarter. Shine Investment Advisory Services Inc. now owns 302 shares of the technology company’s stock worth $28,000 after purchasing an additional 122 shares in the last quarter. Capital Bank & Trust Co purchased a new stake in AMETEK in the 2nd quarter worth $29,000. Berman Capital Advisors LLC lifted its stake in AMETEK by 51.3% in the 2nd quarter. Berman Capital Advisors LLC now owns 454 shares of the technology company’s stock worth $41,000 after purchasing an additional 154 shares in the last quarter. Finally, Ibex Wealth Advisors purchased a new stake in AMETEK in the 2nd quarter worth $52,000. Institutional investors and hedge funds own 86.51% of the company’s stock.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

See Also: Differences Between Momentum Investing and Long Term Investing

Insider Buying and Selling by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.